|
Market Closed -
Börse Stuttgart
15:55:37 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 35.60 EUR | -0.56% |
|
-1.10% | -12.25% |
| 10-07 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| 10-07 | European Equities Traded in US as ADRs Fall in Wednesday Trading | MT |
| Market Cap | 85.69B 95.94B 79.71B 72.5B 137B 9,285B 137B 959B 376B 4,734B 360B 352B 15,192B | P/E 2026 * |
11.4x | P/E 2027 * | 9.93x |
|---|---|---|---|---|---|
| Enterprise Value | 97.02B 109B 90.26B 82.1B 155B 10,514B 156B 1,086B 426B 5,360B 408B 399B 17,202B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.86x |
| Free-Float |
88.34% | Yield 2026 * |
5.95% | Yield 2027 * | 6.29% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNY | Delayed | |
CBOE
| SNY | Real-time | |
|
London S.E.
| 0A2V | Delayed | |
|
Mexican S.E.
| SNY N | End-of-day quote | |
|
Tradegate
| SNW2 | Real-time | |
|
Boerse Muenchen
| SNW2 | Real-time | |
|
Deutsche Boerse AG
| SNW2 | Delayed | |
|
Börse Stuttgart
| SNW2 | Delayed |
Last Transcript: Sanofi
| 1 week | -1.10% | ||
| Current month | -1.65% | ||
| 1 month | -3.76% | ||
| 3 months | -4.28% | ||
| 6 months | -11.39% | ||
| Current year | -12.25% |
| 1 week | 34.6 |  | 36.2 |
| 1 month | 34.6 | | 37.6 |
| 3 years | 34.6 | | 55 |
| 5 years | 34.6 | | 55 |
| 10 years | 30.6 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 65 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | -1.10% | -14.76% | -29.11% | 95.16B | |
| +0.83% | +3.19% | +37.87% | +106.25% | 1,043B | |
| +1.93% | +2.11% | +36.82% | +64.90% | 618B | |
| +1.49% | +5.19% | +19.84% | +85.41% | 481B | |
| +2.26% | +0.90% | +66.40% | +39.33% | 351B | |
| +1.45% | +2.52% | +22.83% | +44.22% | 338B | |
| +1.17% | +0.88% | +11.83% | +34.76% | 269B | |
| +0.89% | -0.28% | -6.31% | +9.65% | 244B | |
| +1.82% | +2.94% | +40.43% | +52.78% | 220B | |
| +2.77% | +4.44% | +29.49% | +101.40% | 182B | |
| Average | +1.73% | +0.28% | +24.44% | +50.96% | 416.3B | |
| Weighted average by Cap. | +1.48% | +0.60% | +30.55% | +67.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.34B 53.01B 44.04B 40.06B 75.63B 5,130B 75.96B 530B 208B 2,615B 199B 195B 8,393B | 50.44B 56.47B 46.92B 42.68B 80.58B 5,465B 80.92B 565B 221B 2,786B 212B 207B 8,942B |
| Net income | 7.46B 8.35B 6.94B 6.31B 11.91B 808B 11.96B 83.48B 32.71B 412B 31.35B 30.66B 1,322B | 8.87B 9.94B 8.26B 7.51B 14.18B 962B 14.24B 99.36B 38.93B 490B 37.31B 36.5B 1,573B |
| Net Debt | 11.34B 12.69B 10.55B 9.59B 18.11B 1,229B 18.19B 127B 49.74B 626B 47.67B 46.63B 2,010B | 8.02B 8.98B 7.46B 6.78B 12.81B 869B 12.87B 89.78B 35.18B 443B 33.72B 32.98B 1,422B |
| Date | Price | Change |
|---|---|---|
| 26-10-09 | €35.60 | -0.56% |
| 26-10-08 | €35.80 | 0.00% |
| 26-10-07 | €35.80 | +2.29% |
| 26-10-06 | €35.00 | -0.57% |
| 26-10-05 | €35.20 | -0.56% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
